Business Context and Reporting Period
Company: Achieve Life Sciences, Inc. (ACHV)
Filing Type: Form 8-K (Current Report)
Date of Report: August 11, 2022
Reporting Period: Second Quarter ended June 30, 2022
Context: The filing serves to announce the issuance of a press release detailing financial results for the second quarter of 2022.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, no specific values for these metrics can be extracted from this document alone.
Material Changes
The filing does not provide comparative data or specific details regarding material changes versus the prior comparable period. It only confirms the announcement of Q2 2022 results.
Guidance, Outlook, and Risks
Management Commentary: The filing indicates that management issued a press release on August 11, 2022, regarding Q2 results, but the text of the commentary is not included in this document.
Guidance and Risks: No specific guidance, outlook, risks, contingencies, or unusual items are detailed in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 11, 2022) for actual Q2 2022 financial figures.
- Verify the company's liquidity position and cash burn rate in the full press release.
- Check for any updated forward-looking guidance or operational milestones mentioned in the press release.
- Confirm the status of the company's listing on the NASDAQ Capital Market.